Development of a Novel AAV Vector Capsid Optimized for OA Gene Therapy

Abstract

Osteoarthritis (OA) is a chronic, degenerative, often crippling disease that primarily affects large weight-bearing joints. OA is most commonly linked to wear and tear of the joints from old age. In younger people, though, it arises from a significant joint injury, one that damages the bones and cartilage (post-traumatic osteoarthritis; PTOA). Indeed, OA one of the primary causes of disability among active duty soldiers and veterans. Despite the constant claims in the media, there is no drug or dietary supplement capable of slowing joint destruction in OA and although some drugs can ease OA joint pain, they can't stop the erosive biological processes.

Open PDF

Document Details

Document Type
Technical Report
Publication Date
Sep 01, 2023
Accession Number
AD1219310

Entities

People

  • Steven C. Ghivizzani

Organizations

  • University of Florida

Tags

Fields of Study

  • Medicine

Readers

  • Molecular Genetics
  • Neurotrauma and Rehabilitation Medicine.
  • Strategic Security Studies

Technology Areas

  • Biotechnology